Okwanjula
Omugejjo gukyagenda mu maaso okuba ekimu ku bisinga okusoomoozebwa mu by’obulamu mu nsi yonna, nga kukwatagana n’embeera ezitawona nga ssukaali, endwadde z’emisuwa n’emisuwa, ne kookolo omu. Wadde ng’enkyukakyuka mu bulamu zikyali ejjinja ery’oku nsonda mu kugejja, abantu bangi ssekinnoomu beetaaga obuyambi obw’enjawulo okusobola okutuuka ku kugejja okw’amakulu era okw’olubeerera. Gye buvuddeko, obujjanjabi obupya obusinziira ku incretin buleese okucamuka mu kunoonyereza ku mugejjo. Mu bino, Retatrutid efunye okufaayo okunene olw’enkola yaayo ey’enjawulo n’ebyava mu kugezesebwa ebisuubiza. Ekiwandiiko kino kijja kwekenneenya ebivudde mu kugezesebwa kw’obujjanjabi okusembyeyo okwekenneenya engeri Retatrutid gy’ekola obulungi mu kujjanjaba omugejjo, okuwa amagezi ku kifo kyayo ekiyinza okukolebwa mu biseera eby’omu maaso eby’okuddukanya obuzito.
Okutegeera Retatrutid n’Enkola yaayo
Retatrutid ye agonist ey’omulembe oguddako erimu ebirungo ebingi etunuulira GLP-1 (glucagon-like peptide-1) , GIP (glucose-dependent insulinotropic polypeptide) , ne glucagon receptors . Enkola eno eya 'triple agonist' eyawula Retatrutid ku ddagala eryasooka nga semaglutide, erigenderera GLP-1 yokka. Nga ekola omulundi gumu ebitundu bisatu ebikwata, Retatrutid ekwata ku kulungamya okwagala okulya, ensaasaanya y’amaanyi, n’okukyusakyusa glucose mu bugazi. Dizayini eno tegenderera kunyigiriza njagala ya mmere yokka wabula n’okwongera ku kwokya kalori, ekigifuula eky’amaanyi ennyo mu kujjanjaba omugejjo.
Obutafaananako ddagala lya bulijjo, enkola ya Retatrutid esobozesa byombi okukendeeza ku mmere gye balya n’okwongera ku nsaasaanya y’amaanyi , ekivaamu ebikolwa bibiri. Ekkubo lino ery’emirundi ebiri liyinza okunnyonnyola lwaki ebivudde mu bujjanjabi mu kusooka biraga nti okugejja kwa maanyi era okuwangaala bw’ogeraageranya n’eddagala eddala eririwo mu kiseera kino.
Ebikulu ebyava mu kugezesebwa kw’obujjanjabi bwa Retatrutid mu mugejjo
Ekimu ku kunoonyereza okusinga okujuliziddwa ku Retatrutid kwe kugezesebwa okw’omutendera ogw’okubiri okwafulumizibwa mu 2023, okwawandiisa abantu abakulu abagejjulukuka oba abagejjulukuka nga tebalina ssukaali. Abeetabye mu kutendekebwa kuno baafunye dose ez’enjawulo eza Retatrutid bw’ogeraageranya n’eddagala lya placebo. Ebivuddemu biraga nti oluvannyuma lwa wiiki 48:
Abeetabye mu kunywa ddoozi ya Retatrutid esinga obunene baakendeeza ku buzito bw’omubiri obutuuka ku bitundu 24%.
Ne ku ddoozi ez’ekigero, okukendeeza ku buzito kwasinga nnyo placebo era ne kugeraageranya bulungi ku data y’okugezesebwa kwa semaglutide.
Enkulaakulana era yalabibwa mu bubonero bw’obulamu bw’enkyukakyuka mu mubiri, omuli glucose mu musaayi, puleesa, n’amasavu.
| Ekiseera ky’okugezesebwa |
Ekibinja kya Placebo |
Retatrutid eya dose ey’ekigero |
Retatrutid eya dose enkulu |
| Wiiki 24 |
~2% okugejja |
~12% okugejja |
~18% okugejja |
| Wiiki 48 |
~3% okugejja |
~17% okugejja |
~24% okugejja |
Ebivuddemu bino biraga nti Retatrutid yandisobodde okutuuka ku kugejja okusemberera bariatric surgery levels , awatali invasiveness of surgical intervention.
Okugerageranya Retatrutid N’obujjanjabi bw’omugejjo obuliwo
Bw’oba weetegereza obulungi bwa Retatrutid, kyetaagisa okugigeraageranya n’obujjanjabi obulala obuteesebwako ennyo:
| Eddagala |
Enkola y’emirimu |
Okugejja kwa wakati mu kugezesebwa |
Ebbanga ly’okugezesebwa |
| Semaglutid (Ekiwuka ekiyitibwa Semaglutid). |
Ekirungo ekiziyiza obulwadde bwa GLP-1 |
15% ku wiiki 68 |
Okuddaabiriza okumala ebbanga eddene kyetaagisa |
| Tirzepatid, eddagala eriyitibwa Tirzepatid |
GLP-1 + GIP eddagala ery’emirundi ebiri |
20% ku wiiki 72 |
Efficacy ey’amaanyi naye nga etandika mpola |
| Okuddamu okukola (Retatrutid). |
GLP-1 + GIP + Ekirungo kya glucagon eky’emirundi esatu |
Okutuuka ku bitundu 24% ku wiiki 48 |
Okuddamu okw’amangu era okw’obuziba |
Bw’ogeraageranya ne semaglutide ne tirzepatide, Retatrutid eraga okugejja amangu nga esobola okuvaamu emigaso mingi egy’ekiseera ekiwanvu. Wadde nga bukyali nnyo okugilangirira nti esinga, enkola yaayo ey’okukwata ebitundu bisatu erabika ng’ewa empenda.
Obukuumi n’ebikosa ebirabibwa mu kugezesebwa okw’obujjanjabi
Nga bwe kiri ku ddagala eddala erikozesa incretin, ebizibu ebiva mu lubuto bye byasinga okuloopebwa ku Retatrutid. Mu bino mwalimu okuziyira, okusiiyibwa n’ekiddukano naddala mu wiiki ezisooka ng’ajjanjabwa. Wabula obubonero obusinga bwakendeera okumala ekiseera ng’emibiri gy’abeetabye mu kutendekebwa gitereera. Ekikulu, ebizibu eby’amaanyi byali tebitera kubaawo, era abanoonyereza ku kugezesebwa baategeeza nti okutwalira awamu Retatrutid yali egumiikiriza bulungi.
Ebikwata ku byokwerinda eby’ekiseera ekiwanvu bikyakung’aanyizibwa, naye ebikwata ku by’okwerinda eby’ekiseera ekitono okutuuka mu kiseera eky’omu makkati bizzaamu amaanyi. Bw’ogeraageranya ne semaglutide ne tirzepatide, Retatrutid telabika nga ereeta ebika bipya eby’ebizibu naye ejja kwetaagisa okulondoola obulabe obuyinza okubaawo ng’obulwadde bw’olubuto oba ensonga z’ekibumba, ekikwatagana n’ekika kino eky’eddagala.
Ebirungi Ebiyinza Okuva mu Retatrutid Okusinga Enzijanjaba Endala
Ebirungi eby’enjawulo ebiwerako byeyoleka ng’olowooza ku busobozi bwa Retatrutid:
Ebiva mu kugejja eby’amaanyi – Obujulizi obusooka bulaga ebitundu ebinene eby’okukendeeza ku buzito bw’ogeraageranya n’eddagala ery’omutindo eririwo kati.
Okulongoosa mu mubiri – Okusukka obuzito, Retatrutid yalongoosa nnyo kolesterol, puleesa, n’okuwulira insulini.
Dual effect on intake and expenditure – Obusobozi bwayo okutumbula ensaasaanya y’amaanyi buyinza okufuula okukuuma obuzito okusoboka.
Okutandika amangu ebivuddemu – Okukendeera okw’amaanyi kwalabibwa nga bukyali mu wiiki 24, ekiyinza okulongoosa okusikiriza kw’omulwadde n’okunywerera.
Okugatta kuno okw’emigaso kuyinza okuteeka Retatrutid ng’obujjanjabi obw’eddagala obw’olunyiriri olusooka singa data ey’ekiseera ekiwanvu esigala nga ekwatagana.
Ebikoma n’Ebibuuzo Ebisigadde Okuva mu Kugezesebwa okw’Obujjanjabi
Wadde ng’ebivuddemu biwuniikiriza, obuzibu obuwerako n’ebibuuzo ebitannaba kuddibwamu bikyaliwo:
Ebbanga ly’okugezesa : Okunoonyereza okusinga tekusukka wiiki 48, kale obuwangaazi bw’okugejja tebukakafu.
Obukuumi obw’ekiseera ekiwanvu : Wadde ng’ebiwandiiko ebisookerwako biraga nti bigumiikiriza, obulabe obuyinza okuva mu kukozesa okumala ebbanga eddene bulina okunnyonnyolwa.
Ebisale n’okutuuka ku ddagala : Singa biba bya bbeeyi okufaananako n’eddagala eddala erya GLP-1, ebbeeyi eyinza okukomya okukozesa abantu bangi.
Obulung’amu mu nsi entuufu : Ensengeka z’okugezesebwa mu malwaliro zaawukana ku kunywerera mu nsi entuufu, era obulungi obw’omugaso bwetaaga okukakasibwa.
Okusoomoozebwa kuno kulaga obukulu bw’okunoonyereza okugenda mu maaso mu mutendera ogw’okusatu n’okukkakkana ng’okulondoola oluvannyuma lw’okutunda.
Entunula mu biseera eby’omu maaso: Retatrutid eyinza okuddamu okunnyonnyola obujjanjabi bw’omugejjo?
Singa okunoonyereza okw’omutendera ogw’okusatu n’okumala ebbanga eddene kukakasa obulungi bwa Retatrutid n’obukuumi bwayo, kiyinza okukyusa ennyo embeera y’obujjanjabi bw’omugejjo. Nga okugejja kusemberera ebiva mu kulongoosebwa, Retatrutid eyinza okufuuka eky’okulonda ekitali kya kuyingirira eri abantu ssekinnoomu abatasobola oba abatayagala kulongoosebwa mu ngeri ya bariatric. Emigaso gyayo emigazi mu nkyukakyuka y’emmere era giraga nti eyinza okukozesebwa mu kuziyiza oba okuddukanya embeera ezikwatagana nga ssukaali ow’ekika eky’okubiri n’endwadde z’emisuwa.
Mu bufunzi
Ebiwandiiko ebikwata ku kugezesebwa kw’obujjanjabi ku Retatrutid biraga obusobozi bwayo ng’emu ku bujjanjabi bw’eddagala obusinga okukola obulungi ku mugejjo okutuusa kati. Nga egatta triple receptor gonism n’okukendeeza ku buzito obw’amaanyi, emigaso mu nkyukakyuka y’emmere, n’ebizibu ebigumiikiriza, Retatrutid etuwa essuubi eri omulembe omupya mu kuddukanya obuzito. Wadde ng’ebibuuzo bikyaliwo ku bukuumi obw’ekiseera ekiwanvu, omuwendo, n’okutuuka ku bantu, obujulizi obw’amangu awatali kugaanirwa busuubiza. Mu kiseera kino, Retatrutid ekiikirira ekiyinza okukyusa omuzannyo mu bujjanjabi bw’omugejjo nga bwe balindirira okukakasibwa okulala okuva mu kunoonyereza okugenda mu maaso.
Ebibuuzo ebibuuzibwa
1. Okugejja kimeka kye kiyinza okusuubirwa ne Retatrutid?
Ebiwandiiko ebikwata ku kugezesebwa mu bujjanjabi biraga nti omugejjo gukendeera okutuuka ku bitundu 24% ku buzito bw’omubiri oluvannyuma lwa wiiki 48, nga kino kisinga ku ddagala erisinga obungi eririwo.
2. Retatrutid terina bulabe eri okukozesebwa okumala ebbanga eddene?
Okunoonyereza okuliwo kati kulaga nti okutwalira awamu tekirina bulabe era kigumiikiriza bulungi, naye ebikwata ku bulamu obw’ekiseera ekiwanvu bikyalina okwetaagisa okukakasa obukuumi obusukka omwaka gumu.
3. Retatrutid bw’ogeraageranya etya ku semaglutide oba tirzepatide?
Retatrutid eraga obusobozi obusingako obw’okugejja ng’ebivaamu bitandika mangu, olw’enkola yaayo ey’okugejja emirundi esatu.
4. Biki ebiva mu Retatrutid?
Ebizibu ebisinga okuvaamu bye biva mu lubuto omuli okuziyira n’ekiddukano, ebitera okukendeera okumala ekiseera.
5. Retatrutid ejja kufuuka ddi okufunibwa abantu bangi?
Kikyanoonyezebwa mu malwaliro. Okubeerawo okugazi kujja kusinziira ku biva mu kugezesebwa okugenda mu maaso okw’omutendera ogw’okusatu n’okukkirizibwa okuva mu mateeka.
